Global Lower GI Series Market Growth (Status and Outlook) 2023-2029

Global Lower GI Series Market Growth (Status and Outlook) 2023-2029

A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumto view your large intestine. The barium will make your large intestine more visible on an x-ray. The two types of lower GI series are a single-contrast lower GI series, which uses only barium and a double-contrast or air-contrast lower GI series, which uses both barium and air for a clearer view of your large intestine.

LPI (LP Information)' newest research report, the “Lower GI Series Industry Forecast” looks at past sales and reviews total world Lower GI Series sales in 2022, providing a comprehensive analysis by region and market sector of projected Lower GI Series sales for 2023 through 2029. With Lower GI Series sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lower GI Series industry.

This Insight Report provides a comprehensive analysis of the global Lower GI Series landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lower GI Series portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lower GI Series market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lower GI Series and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lower GI Series.

The global Lower GI Series market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

A lower GI series can help a doctor find the cause of bleeding from anus, changes in bowel activity, chronic diarrhea, pain in abdomen and unexplained weight loss.

This report presents a comprehensive overview, market shares, and growth opportunities of Lower GI Series market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Double-Contrast
Single-Contrast

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eisai
Cadila Pharmaceuticals
Purdue Pharma
Peacehealth
Novadaq
Astrazeneca
Ironwood Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.